The Fas counterattack: a molecular mechanism of tumor immune privilege

Mol Med. 1997 May;3(5):294-300.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Apoptosis*
  • Humans
  • Neoplasms / immunology*
  • Neoplasms / therapy
  • Oligonucleotides, Antisense / therapeutic use
  • Tumor Escape / immunology*
  • fas Receptor* / drug effects
  • fas Receptor* / immunology

Substances

  • Oligonucleotides, Antisense
  • fas Receptor